BPA Call FA301624A0046-HT009025FG0230019
Award Date 2/13/25
Potential Completion Date 9/30/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Portage, MI 49002, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $49,732.62 to Phadia US Inc.'s Immunodiagnostics Division on December 4, 2025, for allergy testing services that provide critical information in the detection and management of allergic reactions. The contract, which is set to be completed by September 30, 2026, will be performed in Portage, Michigan. As a subsidiary of Thermo Fisher Scientific specializing in advanced allergy and autoimmune...
- This is a federal contract award to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, to provide reagents required for allergy testing. The contract is a Blanket Purchase Agreement (BPA) Call with the Defense Health Agency, a defense agency, with a ceiling value of $24,960.42 and a completion date of September 30, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation. Phadia US Inc. is a foreign-owned, for-profit organization that specializes in...
- This is a firm-fixed-price contract awarded by the Defense Health Agency to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for the manufacture of in-vitro diagnostic substances. The $24,960.42 contract has a period of performance through September 30, 2025 and was awarded on June 17, 2025 without a set-aside designation. Phadia US Inc. specializes in advanced allergy and autoimmune testing solutions, providing IMMUNOCAP SYSTEM ANALYZERS and related equipment, software, supplies,...
- The Defense Health Agency awarded a mission-critical contract to Phadia US Inc.'s Immunodiagnostics Division on August 1, 2025, valued at $49,920.38 through a Blanket Purchase Agreement (BPA) call. This firm-fixed-price order procures specialized allergy testing reagents required to support healthcare providers across San Antonio military treatment facilities and other Department of Defense medical installations. The reagents are essential for the detection and management of allergic...
- This firm-fixed-price Blanket Purchase Agreement (BPA) call was awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific Inc. The contract has a ceiling value of $600,000.00 and no set-aside designation. It provides for the procurement of immunodiagnostic analyzers, reagents, and consumables used for allergen and asthma testing to support military medical readiness and research programs. This contract is part of a larger BPA awarded by...
- The Defense Health Agency awarded a $20,580 firm-fixed-price Blanket Purchase Agreement (BPA) call to Phadia US Inc.'s Immunodiagnostics Division on August 26, 2025, with completion targeted for September 30, 2025. This contract procures allergen-specific immunoglobulin E (IgE) reagents essential for allergy testing and management across the San Antonio military treatment facility and 153 additional military healthcare installations. The reagent supply supports critical diagnostic capabilities...
- This is a firm-fixed-price BPA call issued by the U.S. Army Medical Command (MEDCOM) in Germany for the month of December 2016, awarded to Phadia US Inc., a subsidiary of Thermo Fisher Scientific. The contract, valued at $600,000.00, is for the procurement of Phadia's proprietary IMMUNOCAP SYSTEM ANALYZERS and related equipment, supplies, and technical support to support military medical readiness and research programs. Phadia has been the sole source provider for these types of allergy...
- The Defense Health Agency awarded a Blanket Purchase Agreement call valued at $49,921.55 to Phadia US Inc.'s Immunodiagnostics Division on July 23, 2025, with completion targeted for September 30, 2025. Under this firm fixed-price contract, Phadia will supply allergy testing reagents to support healthcare providers across the San Antonio military treatment facility and 153 additional military medical installations. The reagents are essential for detecting and managing allergic reactions across...
- This is a firm-fixed-price BPA call order awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific. The contract, valued at $600,000.00, is for allergy and asthma testing products and services to support military medical readiness and research programs. Phadia has received multiple prime federal contracts from agencies such as the Defense Health Agency and Department of the Air Force for its proprietary IMMUNOCAP SYSTEM ANALYZERS and related...
- This is a firm-fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for $600,000.00. The BPA call is for allergy and asthma testing solutions, including analyzers, reagents, and consumables to support military medical readiness and research programs. Phadia US Inc. has been the sole source provider for many similar MEDCOM contracts due to its proprietary products being the only...